CVE & CISA-KEV Catalog

CVE-2015-3953

CRITICALEPSS 78th pctl
9.8
CVSS v3
NVD

Description

Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

How to fix

No published remediation has been found for this vulnerability's affected products yet.

Mitigation guidance may be in the linked vendor advisories in the References section below.

CVSS v3 Vector

Exploitability

Attack VectorNetwork
Attack ComplexityLow
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityHigh
AvailabilityHigh

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploit Intelligence

1.97%probability of exploitation in 30 days
78thpercentile

Elevated risk: more likely to be exploited than 78% of all known CVEs.

References

Embed a live status badge for CVE-2015-3953
CVE-2015-3953 severity badge

Markdown

[![CVE-2015-3953](https://tridentstack.com/cve/badge/CVE-2015-3953.svg)](https://tridentstack.com/cve/CVE-2015-3953)

HTML

<a href="https://tridentstack.com/cve/CVE-2015-3953"><img src="https://tridentstack.com/cve/badge/CVE-2015-3953.svg" alt="CVE-2015-3953"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.